- AU$6.98m
- AU$8.23m
- AU$4.53m
Australia Stock Exchange release from ACRUX : Human Capital and Nomination Committee Charter
Australia Stock Exchange release from ACRUX : Code of Conduct
Brief: Acrux Ltd Receives FDA Approval For Generic Efinaconazole Solution
Australia's Acrux soars on U.S. FDA nod for generic version of antifungal drug
Australia Stock Exchange release from ACRUX : Acrux Receives FDA Approval - Generic Efinaconazole Solution
Australia Stock Exchange release from ACRUX : PRE_NR Ends: 09:51:23
Australia Stock Exchange release from ACRUX : Notification of cessation of securities - ACR
Brief: Acrux Says Joanna Johnson Has Been Appointed To Role Of Chief Financial Officer
Australia Stock Exchange release from ACRUX : Change in Company Secretary
Australia Stock Exchange release from ACRUX : Change of Director's Interest Notice - Ross Dobinson
Australia Stock Exchange release from ACRUX : Application for quotation of securities - ACR
Australia's Acrux falls to over 1-yr low on U.S. drug patent litigation
Brief: Acrux Announces Almirall LLC Patent Litigation Against Acrux
Australia Stock Exchange release from ACRUX : Acrux confirms patent challenge
Australia Stock Exchange release from ACRUX : PRE_NR Ends: 08:43:45
Australia Stock Exchange release from ACRUX : Final Director's Interest Notice - amended
Australia Stock Exchange release from ACRUX : Final Director's Interest Notice - Mr Norman Gray
Australia Stock Exchange release from ACRUX : Initial Director's Interest Notice - Mr Don Brumley
Australia Stock Exchange release from ACRUX : Acrux Limited Announces Board Appointment